Published in Arterioscler Thromb on December 01, 1994
Flow rate and fibrin fiber alignment. J Thromb Haemost (2010) 1.19
Redistribution and hemostatic action of recombinant activated factor VII associated with platelets. Am J Pathol (2011) 0.85
Role of sodium tungstate as a potential antiplatelet agent. Drug Des Devel Ther (2015) 0.76
The impact of blood shear rate on arterial thrombus formation. Future Sci OA (2015) 0.76
Open reading frame 1a-encoded subunits of the arterivirus replicase induce endoplasmic reticulum-derived double-membrane vesicles which carry the viral replication complex. J Virol (1999) 3.51
Human blood platelet adhesion to artery subendothelium is mediated by factor VIII-Von Willebrand factor bound to the subendothelium. Nature (1979) 3.06
Use of claims data systems to evaluate health care outcomes. Mortality and reoperation following prostatectomy. JAMA (1987) 2.84
Performance of the ACG case-mix system in two Canadian provinces. Med Care (2001) 2.27
Induction of transforming growth factor-alpha in activated human alveolar macrophages. Cell (1988) 2.13
Ultrastructural and immunocytochemical characterization of autophagic vacuoles in isolated hepatocytes: effects of vinblastine and asparagine on vacuole distributions. Exp Cell Res (1995) 2.03
Non-structural proteins 2 and 3 interact to modify host cell membranes during the formation of the arterivirus replication complex. J Gen Virol (2001) 1.93
Using administrative data to describe casemix: a comparison with the medical record. J Clin Epidemiol (1994) 1.87
Pulmonary aspergillosis: early diagnosis improves survival. Respiration (1995) 1.74
Functional overlap between two classes of matrix-degrading proteases in wound healing. EMBO J (1999) 1.69
Lactational competence and involution of the mouse mammary gland require plasminogen. Development (2000) 1.48
Shear-induced platelet activation and platelet microparticle formation at blood flow conditions as in arteries with a severe stenosis. Arterioscler Thromb Vasc Biol (1997) 1.46
Can blood flow assays help to identify clinically relevant differences in von Willebrand factor functionality in von Willebrand disease types 1-3? J Thromb Haemost (2007) 1.46
A perfusion chamber developed to investigate platelet interaction in flowing blood with human vessel wall cells, their extracellular matrix, and purified components. J Lab Clin Med (1983) 1.44
Pulmonary infiltrates in patients with haematologic malignancies: clinical usefulness of non-invasive bronchoscopic procedures. Eur J Haematol (1995) 1.43
Differentiation of benign from malignant superficial lymphadenopathy: the role of high-resolution US. Radiology (1992) 1.43
Characterization of vaccinia virus intracellular cores: implications for viral uncoating and core structure. J Virol (2000) 1.40
Housing subsidies and pediatric undernutrition. Arch Pediatr Adolesc Med (1995) 1.40
Role of factor VIII-von Willebrand factor and fibronectin in the interaction of platelets in flowing blood with monomeric and fibrillar human collagen types I and III. J Clin Invest (1985) 1.40
Evidence for identity between the hexokinase-binding protein and the mitochondrial porin in the outer membrane of rat liver mitochondria. Biochim Biophys Acta (1982) 1.33
Nucleotide sequence of the cDNA coding for human complement C1r. Biochemistry (1986) 1.29
Structure and assembly of intracellular mature vaccinia virus: thin-section analyses. J Virol (2001) 1.28
High preoperative plasma tissue inhibitor of metalloproteinase-1 levels are associated with short survival of patients with colorectal cancer. Clin Cancer Res (2000) 1.27
Identification and characterization of the pore-forming protein in the outer membrane of rat liver mitochondria. Biochim Biophys Acta (1982) 1.26
Quantitation of TIMP-1 in plasma of healthy blood donors and patients with advanced cancer. Br J Cancer (1999) 1.24
Red blood cell size is important for adherence of blood platelets to artery subendothelium. Blood (1983) 1.23
The role of platelet membrane glycoproteins Ib and IIb-IIIa in platelet adherence to human artery subendothelium. Br J Haematol (1986) 1.20
Deficiency of platelet membrane glycoprotein Ia associated with a decreased platelet adhesion to subendothelium: a defect in platelet spreading. Blood (1986) 1.20
Skin involvement in scleroderma--where histological and clinical scores meet. Rheumatology (Oxford) (2007) 1.20
Directed plasminogen activation at the surface of normal and malignant cells. Adv Cancer Res (1991) 1.17
Cloning and expression of a cDNA coding for a human monocyte-derived plasminogen activator inhibitor. Proc Natl Acad Sci U S A (1988) 1.17
Soluble urokinase plasminogen activator receptor in plasma of patients with inflammatory rheumatic disorders: increased concentrations in rheumatoid arthritis. Ann Rheum Dis (1999) 1.15
Pulmonary nodules: experimental and clinical studies at low-dose CT. Radiology (1999) 1.14
Subendothelial proteins and platelet adhesion. von Willebrand factor and fibronectin, not thrombospondin, are involved in platelet adhesion to extracellular matrix of human vascular endothelial cells. Arteriosclerosis (1986) 1.12
Rat mammary carcinoma cells secrete active collagenase and activate latent enzyme in the stroma via plasminogen activator. Int J Cancer (1981) 1.12
In-vitro high-resolution ultrasonography of benign and malignant lymph nodes. A sonographic-pathologic correlation. Invest Radiol (1993) 1.10
Presence of urokinase-type plasminogen activator receptor in urine of cancer patients and its possible clinical relevance. Lab Invest (1999) 1.10
Seasonal variation in weight-for-age in a pediatric emergency room. Public Health Rep (1996) 1.10
DDAVP enhances platelet adherence and platelet aggregate growth on human artery subendothelium. Blood (1984) 1.10
Von Willebrand factor in the vessel wall mediates platelet adherence. Blood (1985) 1.09
Storage of vitamin A in extrahepatic stellate cells in normal rats. J Lipid Res (1997) 1.09
Structure and assembly of intracellular mature vaccinia virus: isolated-particle analysis. J Virol (2001) 1.05
Internalization of retinol-binding protein in parenchymal and stellate cells of rat liver. J Lipid Res (1990) 1.04
Coexistence of non-Hodgkin's lymphoma and non-small cell lung carcinoma: diagnosis and treatment. Thorac Cardiovasc Surg (2002) 1.04
The effects of cosmetic surgery on body image, self-esteem, and psychological problems. J Plast Reconstr Aesthet Surg (2008) 1.04
Immunocytochemical localization of Shc and activated EGF receptor in early endosomes after EGF stimulation of HeLa cells. J Histochem Cytochem (2000) 1.03
Inactive proenzyme to tissue-type plasminogen activator from human melanoma cells, identified after affinity purification with a monoclonal antibody. EMBO J (1984) 1.03
Phosphorylation sites in the integrin beta3 cytoplasmic domain in intact platelets. J Biol Chem (1999) 1.03
Antibody penetration into LR-White sections. Micron (1994) 1.02
Binding of factor VIII-von Willebrand factor to human arterial subendothelium precedes increased platelet adhesion and enhances platelet spreading. J Lab Clin Med (1981) 1.02
Adhesion of platelets to human artery subendothelium: effect of factor VIII-von Willebrand factor of various multimeric composition. Blood (1984) 1.01
Minimal exclusion of plasma membrane proteins during retroviral envelope formation. Proc Natl Acad Sci U S A (2000) 1.01
Treatment of severe Candida infections in high-risk patients in Germany: consensus formed by a panel of interdisciplinary investigators. Eur J Clin Microbiol Infect Dis (2002) 1.00
Distribution and lateral mobility of the urokinase-receptor complex at the cell surface. J Histochem Cytochem (1993) 1.00
Gastrojejunal kinetics and the digestion of [15N]beta-lactoglobulin and casein in humans: the influence of the nature and quantity of the protein. Am J Clin Nutr (1996) 0.99
Platelet adherence to subendothelium of human arteries in pulsatile and steady flow. Thromb Res (1981) 0.99
Minactivin: a human monocyte product which specifically inactivates urokinase-type plasminogen activators. Eur J Biochem (1983) 0.98
Urokinase-type plasminogen activator in colorectal carcinomas and adenomatous polyps: quantitative expression of active and proenzyme. Int J Cancer (1988) 0.98
Plasminogen activation at the cell surface-matrix interface. Cell Differ Dev (1990) 0.97
Blood flow and antithrombotic drug effects. Am Heart J (1998) 0.95
Further study of the increased mortality following transurethral prostatectomy: a chart-based analysis. J Urol (1990) 0.94
Helical CT of pulmonary nodules in patients with extrathoracic malignancy: CT-surgical correlation. AJR Am J Roentgenol (1999) 0.94
Functional domains on von Willebrand factor. Recognition of discrete tryptic fragments by monoclonal antibodies that inhibit interaction of von Willebrand factor with platelets and with collagen. J Clin Invest (1984) 0.94
Prognostic values of cathepsin B and carcinoembryonic antigen in sera of patients with colorectal cancer. Clin Cancer Res (1998) 0.94
Preparation and characterization of human bone marrow-derived macrophages. J Leukoc Biol (1985) 0.94
Adhesion of leukocytes to growing arterial thrombi. Thromb Haemost (1998) 0.93
5-aminoimidazole-4-carboxy-amide-1-beta-D-ribofuranoside treatment ameliorates hyperglycaemia and hyperinsulinaemia but not dyslipidaemia in KKAy-CETP mice. Diabetologia (2001) 0.93
Soft-tissue profile changes in class II treatment. Am J Orthod (1977) 0.92
Immunomorphologic and biochemical identification of the pemphigus foliaceous autoantigen within desmosomes. J Invest Dermatol (1992) 0.92
A perfusion chamber developed to investigate thrombus formation and shear profiles in flowing native human blood at the apex of well-defined stenoses. Arterioscler Thromb (1994) 0.92
Collagen surfaces to measure thrombus formation under flow: possibilities for standardization. J Thromb Haemost (2011) 0.91
Congenital tracheoesophageal fistulas in adults. Ann Otol Rhinol Laryngol (1976) 0.91
Collagen induced thrombus formation at the apex of eccentric stenoses--a time course study with non-anticoagulated human blood. Thromb Haemost (1996) 0.91
Minactivin expression in human monocyte and macrophage populations. Blood (1985) 0.90
Monoclonal antibodies inhibitory to human plasmin. Definitive demonstration of a role for plasmin in activating the proenzyme of urokinase-type plasminogen activator. Eur J Biochem (1986) 0.89
Induction of morphological differentiation of human neuroblastoma cells is accompanied by induction of tissue-type plasminogen activator. J Neurosci Res (1989) 0.89
Proteolytic activity in leg ulcer exudate. Exp Dermatol (1993) 0.89
Shear rate-dependent impairment of thrombus growth on collagen in nonanticoagulated blood from patients with von Willebrand disease and hemophilia A. Blood (1992) 0.89
Effects of ionic and nonionic contrast media on endothelium and on arterial thrombus formation. Acta Radiol (1996) 0.88
Role of 4 platelet membrane glycoprotein polymorphisms on experimental arterial thrombus formation in men. Blood (2001) 0.88
The resistance of fibrin-stimulated tissue plasminogen activator to inactivation by a class PAI-2 inhibitor (minactivin). Thromb Res (1987) 0.88
Reduced effect of aspirin on thrombus formation at high shear and disturbed laminar blood flow. Thromb Haemost (1996) 0.87
Quantification of tissue inhibitor of metalloproteinases 2 in plasma from healthy donors and cancer patients. Scand J Immunol (2005) 0.87
Soluble urokinase receptor released from human carcinoma cells: a plasma parameter for xenograft tumour studies. Br J Cancer (1999) 0.87
Retinoids increase urokinase-type plasminogen activator production by human retinal pigment epithelial cells in culture. Invest Ophthalmol Vis Sci (1993) 0.87
Hepatosplenic candidiasis, a late manifestation of Candida septicaemia in neutropenic patients with haematologic malignancies. Blut (1990) 0.87
Effect of aspirin and epinephrine on experimentally induced thrombogenesis in dogs. A parallelism between in vivo and ex vivo thrombosis models. Arterioscler Thromb (1991) 0.87
Prourokinase activation on the surface of human rhabdomyosarcoma cells: localization and inactivation of newly formed urokinase-type plasminogen activator by recombinant class 2 plasminogen activator inhibitor. Proc Natl Acad Sci U S A (1990) 0.86
Pulmonary fungal infections in patients with hematological malignancies--diagnostic approaches. Ann Hematol (1995) 0.86
Endocytosis mediated by the mannose receptor in liver endothelial cells. An immunocytochemical study. Eur J Cell Biol (1990) 0.86
A radioassay for proteolytic cleavage of isolated cartilage proteoglycan. I. Separation principles and variables. Anal Biochem (1978) 0.86
Pulmonary fungal infections in immunocompromised patients: incidence and risk factors. Mycoses (1995) 0.86
Immunologic quantification of fibrin deposition in thrombi formed in flowing native human blood. Br J Haematol (1996) 0.86
The complex between urokinase and its type-1 inhibitor in primary breast cancer: relation to survival. Cancer Res (2000) 0.85
Transfer of retinol-binding protein from HepG2 human hepatoma cells to cocultured rat stellate cells. Proc Natl Acad Sci U S A (1993) 0.85
Assessing unmet need for services for pediatric undernutrition. HSPH MPH Student Research Team. Am J Prev Med (1995) 0.85
Amino acid utilization and isotope discrimination of amino nitrogen in nitrogen metabolism of rat liver in vivo. Z Ernahrungswiss (1997) 0.85